1/4
03:39 pm
gral
Small-Cap Standouts: These 3 Stocks Rose Over 300% in 2025 [Yahoo! Finance]
Medium
Report
Small-Cap Standouts: These 3 Stocks Rose Over 300% in 2025 [Yahoo! Finance]
12/27
01:17 pm
gral
GRAIL: Making Strides In Cancer Detection [Seeking Alpha]
Medium
Report
GRAIL: Making Strides In Cancer Detection [Seeking Alpha]
12/15
04:01 pm
gral
GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/1
06:03 pm
gral
GRAIL (NASDAQ:GRAL) was given a new $110.00 price target on by analysts at Morgan Stanley.
Low
Report
GRAIL (NASDAQ:GRAL) was given a new $110.00 price target on by analysts at Morgan Stanley.
12/1
04:01 pm
gral
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Low
Report
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
11/18
04:02 pm
gral
GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference
Medium
Report
GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference
11/17
08:45 am
gral
GRAIL (NASDAQ:GRAL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $85.00 to $105.00. They now have a "buy" rating on the stock.
Medium
Report
GRAIL (NASDAQ:GRAL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $85.00 to $105.00. They now have a "buy" rating on the stock.
11/13
01:00 pm
gral
Grail Q3 Earnings: Massive Stock Gains, Mediocre Performance - I'm Still Not Sold [Seeking Alpha]
Medium
Report
Grail Q3 Earnings: Massive Stock Gains, Mediocre Performance - I'm Still Not Sold [Seeking Alpha]
11/12
04:02 pm
gral
GRAIL Reports Third Quarter 2025 Financial Results
Medium
Report
GRAIL Reports Third Quarter 2025 Financial Results
11/12
08:05 am
gral
GRAIL (NASDAQ:GRAL) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating.
Low
Report
GRAIL (NASDAQ:GRAL) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating.
11/4
04:02 pm
gral
GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference
Medium
Report
GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference
10/29
04:02 pm
gral
GRAIL to Announce Third Quarter 2025 Financial Results
Medium
Report
GRAIL to Announce Third Quarter 2025 Financial Results
10/22
10:26 am
gral
GRAIL (NASDAQ:GRAL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $75.00 to $85.00. They now have a "buy" rating on the stock.
Low
Report
GRAIL (NASDAQ:GRAL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $75.00 to $85.00. They now have a "buy" rating on the stock.